1 |
Tozaki M, Naruo K, Fukuda K. Dynamic contrast-enhanced MDCT of the liver: analysis of the effect of different iodine concentrations with the same total iodine dose in the same chronic liver disease patients. Radiat Med 2005;23:533-538.
|
2 |
Cademartiri F, de Monye C, Pugliese F, et al. High iodine concentration contrast material for noninvasive multislice computed tomography coronary angiography: iopromide 370 versus iomeprol 400. Invest Radiol 2006;41:349-353.
DOI
|
3 |
Setty BN, Sahani DV, Ouellette-Piazzo K, Hahn PF, Shepard JA. Comparison of enhancement, image quality, cost, and adverse reactions using 2 different contrast medium concentrations for routine chest CT on 16-slice MDCT. J Comput Assist Tomogr 2006;30:818-822.
DOI
|
4 |
Sultana S, Morishita S, Awai K, et al. Evaluation of hypervascular hepatocellular carcinoma in cirrhotic liver by means of helical CT: comparison of different contrast medium concentrations within the same patient. Radiat Med 2003;21:239-245.
|
5 |
Tsurusaki M, Sugimoto K, Fujii M, Sugimura K. Multi- detector row helical CT of the liver: quantitative assessment of iodine concentration of intravenous contrast material on multiphasic CT: a prospective randomized study. Radiat Med 2004;22:239-245.
|
6 |
Bonaldi VM, Bret PM, Reinhold C, Atri M. Helical CT of the liver: value of an early hepatic arterial phase. Radiology 1995;197:357-363.
DOI
|
7 |
Ito K, Honjo K, Fujita T, et al. Liver neoplasms: diagnostic pitfalls in cross-sectional imaging. Radiographics 1996;16:273-293.
DOI
|
8 |
Takayasu K, Furukawa H, Wakao F, et al. CT diagnosis of early hepatocellular carcinoma: sensitivity, findings, and CT-pathologic correlation. AJR Am J Roentgenol 1995;164:885-890.
DOI
|
9 |
Cademartiri F, Mollet NR, van der Lugt A, et al. Intravenous contrast material administration at helical 16-detector row CT coronary angiography: effect of iodine concentration on vascular attenuation. Radiology 2005;236:661-665.
DOI
|
10 |
Yanaga Y, Awai K, Nakayama Y, et al. Optimal dose and injection duration (injection rate) of contrast material for depiction of hypervascular hepatocellular carcinomas by multidetector CT. Radiat Med 2007;25:278-288.
DOI
|
11 |
Sahani DV, Soulez G, Chen KM, et al. A comparison of the efficacy and safety of iopamidol-370 and iodixanol-320 in patients undergoing multidetector-row computed tomography. Invest Radiol 2007;42:856-861.
DOI
|
12 |
Romano L, Grazioli L, Bonomo L, et al. Enhancement and safety of iomeprol-400 and iodixanol-320 in patients undergoing abdominal multidetector CT. Br J Radiol 2009;82:204-211.
DOI
|
13 |
Yagyu Y, Awai K, Inoue M, et al. MDCT of hypervascular hepatocellular carcinomas: a prospective study using contrast materials with different iodine concentrations. AJR Am J Roentgenol 2005;184:1535-1540.
DOI
|
14 |
Fleischmann D. Use of high concentration contrast media: principles and rationale-vascular district. Eur J Radiol 2003;45 Suppl 1:S88-S93.
DOI
|
15 |
Fleischmann D. High-concentration contrast media in MDCT angiography: principles and rationale. Eur Radiol 2003;13 Suppl 3:N39-N43.
DOI
|
16 |
Sandstede JJ, Werner A, Kaupert C, et al. A prospective study comparing different iodine concentrations for triphasic multidetector row CT of the upper abdomen. Eur J Radiol 2006;60:95-99.
DOI
|
17 |
Han JK, Kim AY, Lee KY, et al. Factors influencing vascular and hepatic enhancement at CT: experimental study on injection protocol using a canine model. J Comput Assist Tomogr 2000;24:400-406.
DOI
|
18 |
Spielmann AL. Liver imaging with MDCT and high concentration contrast media. Eur J Radiol 2003;45 Suppl 1:S50-S52.
DOI
|
19 |
Bae KT. Peak contrast enhancement in CT and MR angiography: when does it occur and why? Pharmacokinetic study in a porcine model. Radiology 2003;227:809-816.
DOI
|
20 |
Matoba M, Kitadate M, Kondou T, Yokota H, Tonami H. Depiction of hypervascular hepatocellular carcinoma with 64-MDCT: comparison of moderate- and high-concentration contrast material with and without saline flush. AJR Am J Roentgenol 2009;193:738-744.
DOI
|
21 |
Hwang GJ, Kim MJ, Yoo HS, Lee JT. Nodular hepatocellular carcinomas: detection with arterial-, portal-, and delayed-phase images at spiral CT. Radiology 1997;202:383-388.
DOI
|
22 |
Mitsuzaki K, Yamashita Y, Ogata I, Nishiharu T, Urata J, Takahashi M. Multiple-phase helical CT of the liver for detecting small hepatomas in patients with liver cirrhosis: contrast-injection protocol and optimal timing. AJR Am J Roentgenol 1996;167:753-757.
DOI
|
23 |
Bae KT, Heiken JP, Brink JA. Aortic and hepatic peak enhancement at CT: effect of contrast medium injection rate: pharmacokinetic analysis and experimental porcine model. Radiology 1998;206:455-464.
DOI
|
24 |
Yamashita Y, Komohara Y, Takahashi M, et al. Abdominal helical CT: evaluation of optimal doses of intravenous contrast material: a prospective randomized study. Radiology 2000;216:718-723.
DOI
|
25 |
Awai K, Takada K, Onishi H, Hori S. Aortic and hepatic enhancement and tumor-to-liver contrast: analysis of the effect of different concentrations of contrast material at multi-detector row helical CT. Radiology 2002;224:757-763.
DOI
|
26 |
Marchiano A, Spreafico C, Lanocita R, et al. Does iodine concentration affect the diagnostic efficacy of biphasic spiral CT in patients with hepatocellular carcinoma? Abdom Imaging 2005;30:274-280.
DOI
|
27 |
Behrendt FF, Mahnken AH, Stanzel S, et al. Intraindividual comparison of contrast media concentrations for combined abdominal and thoracic MDCT. AJR Am J Roentgenol 2008;191:145-150.
DOI
|
28 |
Schoellnast H, Brader P, Oberdabernig B, et al. High-concentration contrast media in multiphasic abdominal multidetector-row computed tomography: effect of increased iodine flow rate on parenchymal and vascular enhancement. J Comput Assist Tomogr 2005;29:582-587.
DOI
|
29 |
Walkey MM. Dynamic hepatic CT: how many years will it take 'til we learn? Radiology 1991;181:17-18.
DOI
|
30 |
Furuta A, Ito K, Fujita T, Koike S, Shimizu A, Matsunaga N. Hepatic enhancement in multiphasic contrast-enhanced MDCT: comparison of high- and low-iodine-concentration contrast medium in same patients with chronic liver disease. AJR Am J Roentgenol 2004;183:157-162.
DOI
|